Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Manns

Showing results (11-20 of 801) with videos related to

Pageof 81
Sort By:
Deutsches Arzteblatt International|March 2, 2013
Liver cirrhosis, transplantation and organ shortageMichael P Manns
Hepatology (Baltimore, Md.)|February 21, 2013
Immunoglobulin G4-associated cholangitis: dominating immunoglobulin G4-positive clones within the B-cell receptor repertoire indicate light at the end of a long tunnelMichael P Manns
The Lancet. Global Health|September 16, 2017
Hepatitis D virus in Africa: several unmet needsMichael P Manns
Deutsche Medizinische Wochenschrift (1946)|February 7, 2015
[Transboundary research and development in Europe: the EU Scientific Panel for Health]Michael P Manns
Pharmazie in Unserer Zeit|January 4, 2011
[Current Guidelines for treatment of hepatitis B. Correct diagnosis is the prerequisite.]Markus Cornberg, Michael P Manns
Nature Reviews. Gastroenterology & Hepatology|February 5, 2011
Hepatitis in 2010: the dawn of a new era in HCV therapySandra Ciesek, Michael P Manns
Nature Reviews. Gastroenterology & Hepatology|February 1, 2018
Hepatitis: No cure for hepatitis B and D without targeting integrated viral DNA?Markus Cornberg, Michael P Manns
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 11, 2006
Review article: clinical experience with PrometheusKinan Rifai, Michael P Manns
JAMA|December 16, 2004
Treatment of hepatitis C in HIV-infected patients: significant progress but not the final stepMichael P Manns, Heiner Wedemeyer
Antiviral Therapy|May 2, 2022
The curing regimens of HCV: A SWOT analysisMarkus Cornberg, Michael P Manns
Pageof 81

Showing results (11-20 of 801) with videos related to

Sort By:
Pageof 81
Deutsches Arzteblatt International|March 2, 2013
Liver cirrhosis, transplantation and organ shortageMichael P Manns
Hepatology (Baltimore, Md.)|February 21, 2013
Immunoglobulin G4-associated cholangitis: dominating immunoglobulin G4-positive clones within the B-cell receptor repertoire indicate light at the end of a long tunnelMichael P Manns
The Lancet. Global Health|September 16, 2017
Hepatitis D virus in Africa: several unmet needsMichael P Manns
Deutsche Medizinische Wochenschrift (1946)|February 7, 2015
[Transboundary research and development in Europe: the EU Scientific Panel for Health]Michael P Manns
Pharmazie in Unserer Zeit|January 4, 2011
[Current Guidelines for treatment of hepatitis B. Correct diagnosis is the prerequisite.]Markus Cornberg, Michael P Manns
Nature Reviews. Gastroenterology & Hepatology|February 5, 2011
Hepatitis in 2010: the dawn of a new era in HCV therapySandra Ciesek, Michael P Manns
Nature Reviews. Gastroenterology & Hepatology|February 1, 2018
Hepatitis: No cure for hepatitis B and D without targeting integrated viral DNA?Markus Cornberg, Michael P Manns
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 11, 2006
Review article: clinical experience with PrometheusKinan Rifai, Michael P Manns
JAMA|December 16, 2004
Treatment of hepatitis C in HIV-infected patients: significant progress but not the final stepMichael P Manns, Heiner Wedemeyer
Antiviral Therapy|May 2, 2022
The curing regimens of HCV: A SWOT analysisMarkus Cornberg, Michael P Manns
Pageof 81